ASTELLAS PHARMA INC Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
4 No-Brainer Pharmaceutical Stocks To Buy In October
Article By: StockNews
Monday, September 27, 2021 9:00 PM EDT
While the resurgence of COVID-19 cases is driving the demand for vaccines, booster shots, and other related solutions, an aging population is expected to be a key growth driver for the pharmaceutical industry.
In this article: ALPMY, AZN, GSK, JNJ
Read
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
Article By: Benzinga
Friday, August 21, 2020 7:41 AM EDT
Covering today's biggest news in biotech, including upcoming IPO's and which stocks are hitting their 52 week high and lows.
In this article: XERS, AZN, JNJ, PFE, ALPMY, SRNE, EARS, GMAB, BNTX, TLSA, RNLX, KYMR Also: UBX, TRIL, TNDM, MMSI, PACB, REPH, FLGT, FBIO, OTIC, TLGT, SWAV, ALEC, ITRM, CSTL, ATXI, TXG, SONN, KROS, CRDF, NRIX, POAI, PCVX, ENTX, HRMY, HSTO, INBX, NAOV
Read
Huge Biotech M&A Premiums Narrow Perception Gap
Article By: Lipper Alpha Insight
Wednesday, December 4, 2019 6:27 AM EDT
The premiums needed to seal biotechnology acquisitions have always been high, but they’ve reached the stratosphere this year
In this article: ALPMY, BOLD Also: IBB
Read
Medivation's Xtandi Fares Better Than Casodex In Prostate Cancer Trial
Article By: Terry Chrisomalis
Thursday, April 2, 2015 2:57 PM EDT
Shares of Medivation are up about 3% in the trading session after news that Xtandi showed better efficacy than Casodex in a Prostate Cancer clinical trial.
In this article: MDVN, AZN, JNJ, ALPMY
Read

Latest Tweets for $ALPMY

No tweets yet!

PARTNER HEADLINES